Literature DB >> 15376826

Assessing continuity of care practices in substance use disorder treatment programs.

Jeanne A Schaefer1, Ruth Cronkite, Erin Ingudomnukul.   

Abstract

OBJECTIVE: The purpose of this article is to describe the development and psychometric properties of parallel program-level and individual-level versions of the Continuity of Care Practices Survey (CCPS-P and CCPS-I), a measure that assesses four dimensions of continuity of care practices in substance use disorder (SUD) treatment programs. CCPS subscales assess staff efforts to ensure provider continuity, maintain contact with patients, coordinate care among providers and connect patients to community resources.
METHOD: Program-level CCPS data were obtained from directors/coordinators of 129 intensive inpatient/residential and outpatient Department of Veterans Affairs SUD programs. These data were used to examine the internal consistency and discriminant validity of the CCPS-P. A parallel individual-level CCPS-I completed by counselors for 835 patients in a subsample of 28 SUD programs, assessed the continuity of care services that staff provided to individual patients. These data were used to examine the predictive validity of the CCPS-P.
RESULTS: CCPS-P and CCPS-I subscales demonstrated acceptable psychometric properties. Lack of significant correlations between CCPS-P subscales and SUD program characteristics (e.g., size, staffing) provided preliminary evidence for discriminant validity. CCPS-P subscales and the overall CCPS-P score predicted corresponding continuity of care services that staff provided to patients within programs, offering support for predictive validity.
CONCLUSIONS: Managers can use the CCPS to monitor and improve SUD programs' continuity of care practices. The CCPS also enables researchers to determine the impact of continuity of care practices on the engagement of patients in continuing care and outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15376826     DOI: 10.15288/jsa.2004.65.513

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  6 in total

1.  Randomized trial of enhanced profiling in substance abuse treatment.

Authors:  Marilyn Daley; Donald S Shepard; Christopher Tompkins; Robert Dunigan; Sharon Reif; Jennifer Perloff; Lauren Siembab; Constance Horgan
Journal:  Adm Policy Ment Health       Date:  2011-03

Review 2.  Development and Feasibility Testing of the Clinical-Community Linkage Self-Assessment Survey for Community Organizations.

Authors:  Sarah Fishleder; Jeffrey R Harris; Miruna Petrescu-Prahova; Marlana Kohn; Christian D Helfrich
Journal:  Front Public Health       Date:  2022-05-20

3.  Development and psychometric properties of surveys to assess provider perspectives on the barriers and facilitators of effective care transitions.

Authors:  Maurice C Johnson; Helen Liu; Joann Sorra; Jane Brock; Brianna Gass; Jing Li; Jessica Miller Clouser; Karen Hirschman; Deborah Carpenter; Huong Q Nguyen; Mark V Williams
Journal:  BMC Health Serv Res       Date:  2021-05-20       Impact factor: 2.655

4.  Predicting Continuity of Asthma Care Using a Machine Learning Model: Retrospective Cohort Study.

Authors:  Yao Tong; Beilei Lin; Gang Chen; Zhenxiang Zhang
Journal:  Int J Environ Res Public Health       Date:  2022-01-22       Impact factor: 3.390

5.  Measurement properties of questionnaires measuring continuity of care: a systematic review.

Authors:  Annemarie A Uijen; Claire W Heinst; Francois G Schellevis; Wil J H M van den Bosch; Floris A van de Laar; Caroline B Terwee; Henk J Schers
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

6.  Indicators and Measurement Tools for Health Systems Integration: A Knowledge Synthesis.

Authors:  Esther Suter; Nelly D Oelke; Maria Alice Dias da Silva Lima; Michelle Stiphout; Robert Janke; Regina Rigatto Witt; Cheryl Van Vliet-Brown; Kaela Schill; Mahnoush Rostami; Shelanne Hepp; Arden Birney; Fatima Al-Roubaiai; Giselda Quintana Marques
Journal:  Int J Integr Care       Date:  2017-11-13       Impact factor: 5.120

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.